logo

Morphosys Ag (MOR)



Trade MOR now with
  Date
  Headline
5/5/2021 5:09:35 PM MorphoSys Q1 Total Revenues EUR 47.2 Mln Vs EUR 251.2 Mln Last Year
4/19/2021 4:21:31 PM MorphoSys, Incyte Announce First Patient Dosed In Phase 3 InMIND Study
3/15/2021 5:52:35 PM MorphoSys Swings To FY20 Profit
3/15/2021 5:31:22 PM MorphoSys Posts FY20 Revenues Of EUR 327.7 Mln
1/25/2021 4:49:48 PM MorphoSys And I-Mab Announce First Patient Dosed In Phase 1 Study Of MOR210/TJ210
1/5/2021 2:02:54 AM MorphoSys, Incyte Report That Swissmedic Accepted MAA For Tafasitamab
11/11/2020 5:51:21 PM MorphoSys 9-Month Profit Rises
11/11/2020 4:14:26 PM MorphoSys 9-month Group Revenue EUR 291.7 Mln Vs EUR 60.7 Mln Last Year
11/11/2020 4:13:23 PM MorphoSys, Cherry Biolabs Announce Licensing Of Hemibody Technology
11/11/2020 4:04:14 PM Xencor, MorphoSys And Incyte Announce Clinical Collaboration For Tafasitamab In Combination With Plamotamab
11/4/2020 5:24:22 PM MorphoSys Plans To Present Data On Tafasitamab At ASH Annual Meeting
10/27/2020 9:21:23 PM MorphoSys Raises 2020 Outlook
10/19/2020 1:06:09 AM Janssen Receives CHMP Positive Opinion For Tremfya For Treatment Of Adults With PsA In EU